Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of H5N1 and Seasonal Influenza Vaccines
NCT00481065Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2007
- Primary completion
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) in Avian Influenza (AI), sponsored by Novartis. Started Apr 2007; status: completed.
02
Drugs
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00481065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481065.